Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths News Regulatory News (SNWS)

Share Price Information for Smiths News (SNWS)

Share Price is delayed by 15 minutes
Get Live Data
63.80    0.40 (0.63%)
Bid:
64.00
Ask:
65.00
Spread: 1.00 (1.563%)
Market Cap: £154.42m
SNWS Live PriceLast checked at - London Stock Exchange

Intraday Smiths News Share Chart

Director/PDMR Shareholding

13 Feb 2023 10:30

RNS Number : 7261P
Smiths News PLC
13 February 2023
 

Smiths News plc

Director/PDMR Shareholding

 

Deferred Bonus Plan - Exercise and Sale

Pursuant to the grant of nil cost options announced on 31 January 2023 under the Deferred Bonus Plan award, for the deferral of 50% of the FY2022 annual bonus into shares, the Participants named below have subsequently exercised such awards and sold the number of ordinary shares noted in the table below to cover the tax and NI liability levied on the transaction and retained the net number of shares as a result of the exercise of their respective awards. Pursuant to the award, each Participant shall be subject to a dealing restriction over the net balance acquired for a period of two (2) years calculated from the Date of Grant (i.e. until 30 January 2025).

 

Name of Participant

Grant Share Price (£)

Form of Award

Normal Vesting Date

Number of Options Exercised

Number of shares sold

Sell Share Price (£)

Net Number of Shares Acquired

Jonathan Bunting

0.5066

Nil-cost option

30 January 2023

317,449

149,726

0.4900

167,723

Paul Baker

0.5066

Nil-cost option

30 January 2023

180,508

85,138

0.4900

95,370

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jonathan Bunting

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Smiths News plc

b)

 

LEI

 

 

2138004033ONVOOQXB02

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 5p shares

Identification code

ISIN: GB00B17WCR61

b)

 

Nature of the transaction

 

 

Exercise of 317,449 Deferred Bonus Plan (2022) shares.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil consideration

317,449

d)

 

Aggregated information

n/a single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

9 February 2023

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Jonathan Bunting

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Smiths News plc

b)

 

LEI

 

 

2138004033ONVOOQXB02

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 5p shares

Identification code

ISIN: GB00B17WCR61

b)

 

Nature of the transaction

 

 

Sale of 149,726 shares to cover the tax and NI liability arising following exercise of 317,449 Deferred Bonus Plan (2022) shares.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

0.4900p

149,726

d)

 

Aggregated information

n/a single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

9 February 2023

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Baker

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Smiths News plc

b)

 

LEI

 

 

2138004033ONVOOQXB02

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 5p shares

Identification code

ISIN: GB00B17WCR61

b)

 

Nature of the transaction

 

 

Exercise of 180,508 Deferred Bonus Plan (2022) shares.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil consideration

180,508

d)

 

Aggregated information

n/a single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

9 February 2023

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul Baker

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Smiths News plc

b)

 

LEI

 

 

2138004033ONVOOQXB02

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 5p shares

Identification code

ISIN: GB00B17WCR61

b)

 

Nature of the transaction

 

 

Sale of 85,138 shares to cover the tax and NI liability arising following exercise of 180,508 Deferred Bonus Plan (2022) shares.

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

0.4900p

85,138

d)

 

Aggregated information

n/a single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

9 February 2023

f)

 

Place of the transaction

 

 

London Stock Exchange, Main Market

 

 

Person responsible for arranging release of this announcement:

Karen Mills, Deputy Company Secretary

Smiths News plc

Rowan House

Cherry Orchard North

Kembrey Park

Swindon

SN2 8UH

email: cosec@smithsnews.co.uk

LEI: 2138004O33ONVOOQXB02

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUOURROKUUAAR
Date   Source Headline
6th May 20267:00 amRNSInterim Results as at 28 February 2026
19th Mar 20267:00 amRNSContract Renewal with The Guardian
27th Feb 20263:00 pmRNSBlock listing Interim Review
23rd Feb 20267:00 amRNSStatement re Tuffnells Parcels Express Pension
10th Feb 20265:32 pmRNSDirector/PDMR Shareholding - Correction
3rd Feb 20262:18 pmRNSDirector/PDMR Shareholding
29th Jan 20262:25 pmRNSResult of Annual General Meeting
29th Jan 20267:00 amRNSTrading Statement
6th Jan 202611:48 amRNSHolding(s) in Company
16th Dec 20254:55 pmRNSNotice of AGM
12th Dec 20255:15 pmRNSDirector/PDMR Shareholding
9th Dec 20252:11 pmRNSDirector/PDMR Shareholding
3rd Dec 202512:08 pmRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
14th Nov 202510:38 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSPreliminary Results
6th Oct 20257:00 amRNSNotice of Results and CFO Transition
23rd Sep 20257:00 amRNSTrading Statement
1st Sep 20254:20 pmRNSBlock listing Interim Review
31st Jul 20257:00 amRNSAppointment of Chief Financial Officer
7th May 20257:00 amRNSHalf-year Report
28th Mar 20257:00 amRNSTrading Statement
4th Mar 20257:00 amRNSDirectorate Change
28th Feb 202511:27 amRNSBlock listing Interim Review
16th Jan 20251:50 pmRNSResult of AGM
16th Jan 20257:00 amRNSTrading Statement
7th Jan 20257:00 amRNSBoard Changes
13th Dec 20241:13 pmRNSNotice of AGM
12th Dec 20243:09 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSContract Renewal Reach PLC
29th Nov 20242:47 pmRNSDirector/PDMR Shareholding
29th Nov 20242:45 pmRNSDirector/PDMR Shareholding
29th Nov 20242:44 pmRNSDirector/PDMR Shareholding
29th Nov 20242:43 pmRNSDirector/PDMR Shareholding
29th Nov 20249:16 amRNSDirector/PDMR Shareholding
14th Nov 20243:23 pmRNSDirector/PDMR Shareholding
8th Nov 202411:47 amRNSHolding(s) in Company
6th Nov 20242:44 pmRNSHolding(s) in Company
6th Nov 202411:44 amRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSFinal Results
18th Oct 20247:00 amRNSAppointment of Joint Corporate Broker
17th Oct 20249:37 amRNSNotice of Full Year Results
14th Oct 20249:28 amRNSHolding(s) in Company
2nd Oct 20247:00 amRNSPost Close Trading Statement
2nd Sep 20249:46 amRNSBlock listing Interim Review
2nd May 20247:00 amRNSRefinancing Agreement
2nd May 20247:00 amRNSHalf-year Report
18th Apr 20247:00 amRNSNotice of Results
1st Mar 20248:18 amRNSBlock listing Interim Review
31st Jan 202412:55 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.